GB1288020A - - Google Patents
Info
- Publication number
- GB1288020A GB1288020A GB1288020DA GB1288020A GB 1288020 A GB1288020 A GB 1288020A GB 1288020D A GB1288020D A GB 1288020DA GB 1288020 A GB1288020 A GB 1288020A
- Authority
- GB
- United Kingdom
- Prior art keywords
- sept
- phenylalanine
- compounds
- antiviral
- laucine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000000840 anti-viral effect Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- PIVJVCRQCUYKNZ-UHFFFAOYSA-N 2-(benzylazaniumyl)-3-phenylpropanoate Chemical compound C=1C=CC=CC=1CNC(C(=O)O)CC1=CC=CC=C1 PIVJVCRQCUYKNZ-UHFFFAOYSA-N 0.000 abstract 1
- RKQUHHNIJVGMIG-UHFFFAOYSA-N 2-(dodecanoylamino)-3-phenylpropanoic acid Chemical compound CCCCCCCCCCCC(=O)NC(C(O)=O)CC1=CC=CC=C1 RKQUHHNIJVGMIG-UHFFFAOYSA-N 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 1
- 150000001342 alkaline earth metals Chemical class 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- -1 sulphonyl tryptophan Chemical compound 0.000 abstract 1
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Substances CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7071669 | 1969-09-06 | ||
| GB42828/70A GB1269908A (en) | 1969-09-06 | 1970-09-07 | Amino acids having anti-viral effects |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1288020A true GB1288020A (enrdf_load_stackoverflow) | 1972-09-06 |
Family
ID=26264982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1288020D Expired GB1288020A (enrdf_load_stackoverflow) | 1969-09-06 | 1970-09-07 |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB1288020A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0056274A1 (en) * | 1981-01-14 | 1982-07-21 | Takeda Chemical Industries, Ltd. | Indole derivatives and a method for production of peptides |
-
1970
- 1970-09-07 GB GB1288020D patent/GB1288020A/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0056274A1 (en) * | 1981-01-14 | 1982-07-21 | Takeda Chemical Industries, Ltd. | Indole derivatives and a method for production of peptides |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1388358A (en) | Taste-improving formulations of oral penicillins | |
| GB1444733A (en) | Gentlamicin derivatives and process for their production | |
| GB1445995A (en) | Pharmaceutical preparations comprising n-4-2-5-chloro-2-metho xybenzamidoethyl-phenylsulphonyl-n-cyclohexylurea and salts thereof | |
| GB1288020A (enrdf_load_stackoverflow) | ||
| GB1530074A (en) | Rho-acetamidophenol derivatives the preparation thereof and the use of such derivatives as therapeutic agents | |
| GB1270049A (en) | New pharmaceutical product | |
| GB1357813A (en) | Effervescent composition for the treatment of heart diseases | |
| GB1505959A (en) | Pharmaceutical antihypertensive compositions | |
| GB1187546A (en) | Propanolamine derivatives | |
| GB1242976A (en) | A crystalline l-asparaginase preparation | |
| GB1397675A (en) | Proline compounds | |
| GB1518621A (en) | Analgesic composition | |
| GB1367597A (en) | Pyrrolidine derivative | |
| IE35711L (en) | Pharmaceutical compositions | |
| IE33581L (en) | Compositions comprising l-dopa | |
| GB1244348A (en) | Fluorene derivatives | |
| GB1269898A (en) | Amino acid derivatives | |
| GB1269832A (en) | TRICYCLO(4.4.0.0<3.8>)DECAN-1-AMINE AND alpha-METHYLTRICYCLO(4.4.0.0<3.8>)DECAN-1-METHYLAMINE AND PROCESS FOR PREPARING SAME | |
| GB1230468A (enrdf_load_stackoverflow) | ||
| GB1249907A (en) | Process for the sulphonation of a glycopeptide | |
| GB1454390A (en) | Nasal decongestants | |
| GB1250279A (enrdf_load_stackoverflow) | ||
| GB1242963A (en) | Novel benzazepine derivative | |
| GB1305738A (enrdf_load_stackoverflow) | ||
| CA955176A (en) | Pharmaceutical compositions containing a sympathomimetic amine and a 2-amino (or substituted amino)-4-alkyl-5-oxo-6-alkyl-4,5-dihydro-s-triazolo(1,5-a)pyrimidine derivative |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |